114
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prolonged Grief Disorder: Psychometric Validation of Criteria Proposed for DSM-V and ICD-11

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Holly Prigerson and colleagues tested the psychometric validity of criteria for prolonged grief disorder (PGD) to enhance the detection and care of bereaved individuals at heightened risk of persistent distress and dysfunction.

          Abstract

          Background

          Bereavement is a universal experience, and its association with excess morbidity and mortality is well established. Nevertheless, grief becomes a serious health concern for a relative few. For such individuals, intense grief persists, is distressing and disabling, and may meet criteria as a distinct mental disorder. At present, grief is not recognized as a mental disorder in the DSM-IV or ICD-10. The goal of this study was to determine the psychometric validity of criteria for prolonged grief disorder (PGD) to enhance the detection and potential treatment of bereaved individuals at heightened risk of persistent distress and dysfunction.

          Methods and Findings

          A total of 291 bereaved respondents were interviewed three times, grouped as 0–6, 6–12, and 12–24 mo post-loss. Item response theory (IRT) analyses derived the most informative, unbiased PGD symptoms. Combinatoric analyses identified the most sensitive and specific PGD algorithm that was then tested to evaluate its psychometric validity. Criteria require reactions to a significant loss that involve the experience of yearning (e.g., physical or emotional suffering as a result of the desired, but unfulfilled, reunion with the deceased) and at least five of the following nine symptoms experienced at least daily or to a disabling degree: feeling emotionally numb, stunned, or that life is meaningless; experiencing mistrust; bitterness over the loss; difficulty accepting the loss; identity confusion; avoidance of the reality of the loss; or difficulty moving on with life. Symptoms must be present at sufficiently high levels at least six mo from the death and be associated with functional impairment.

          Conclusions

          The criteria set for PGD appear able to identify bereaved persons at heightened risk for enduring distress and dysfunction. The results support the psychometric validity of the criteria for PGD that we propose for inclusion in DSM-V and ICD-11.

          Please see later in the article for Editors' Summary

          Editors' Summary

          Background

          Virtually everyone loses someone they love during their lifetime. Grief is an unavoidable and normal reaction to this loss. After the death of a loved one, bereaved people may feel sadness, anger, guilt, anxiety, and despair. They may think constantly about the deceased person and about the events that led up to the person's death. They often have physical reactions to their loss—problems sleeping, for example—and they may become ill. Socially, they may find it difficult to return to work or to see friends and family. For most people, these painful emotions and thoughts gradually diminish, usually within 6 months or so of the death. But for a few people, the normal grief reaction lingers and becomes increasingly debilitating. Experts call this complicated grief or prolonged grief disorder (PGD). Characteristically, people with PGD have intrusive thoughts and images of the deceased person and a painful yearning for his or her presence. They may also deny their loss, feel desperately lonely and adrift, and want to die themselves.

          Why Was This Study Done?

          PGD is not currently recognized as a mental disorder although it meets the requirements for one given in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, 4 th Edition (DSM-IV) and in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems, 10 thEdition (ICD-10) . Before PGD can be recognized as a mental disorder (and included in DSM-V and ICD-11), bereavement and mental-health experts need to agree on standardized criteria for PGD. Such criteria would be useful because they would allow researchers and clinicians to identify risk factors for PGD and to find ways to prevent PGD. They would also help to ensure that people with PGD get appropriate treatments such as psychotherapy to help them change their way of thinking about their loss and re-engage with the world. Recently, a panel of experts agreed on a consensus list of symptoms for PGD. In this study, the researchers undertake a field trial to develop and evaluate algorithms (sets of rules) for diagnosing PGD based on these symptoms.

          What Did the Researchers Do and Find?

          The researchers used “item response theory” (IRT) to derive the most informative PGD symptoms from structured interviews of nearly 300 people who had recently lost a close family member. These interviews contained questions about the consensus list of symptoms; each participant was interviewed two or three times during the two years after their spouse's death. The researchers then used “combinatoric” analysis to identify the most sensitive and specific algorithm for the diagnosis of PGD. This algorithm specifies that a bereaved person with PGD must experience yearning (physical or emotional suffering because of an unfulfilled desire for reunion with the deceased) and at least five of nine additional symptoms. These symptoms (which include emotional numbness, feeling that life is meaningless, and avoidance of the reality of the loss) must persist for at least 6 months after the bereavement and must be associated with functional impairment. Finally, the researchers show that individuals given a diagnosis of PGD 6–12 months after a death have a higher subsequent risk of mental health and functional impairment than people not diagnosed with PGD.

          What Do These Findings Mean?

          These findings validate a set of symptoms and a diagnostic algorithm for PGD. Because most of the study participants were elderly women who had lost their husband, further validation is needed to check that these symptoms and algorithm also apply to other types of bereaved people such as individuals who have lost a child. For now, though, these findings support the inclusion of PGD in DSM-V and ICD-11 as a recognized mental disorder. Furthermore, the availability of a standardized way to diagnose PGD will help clinicians identify the minority of people who fail to adjust successfully to the loss of a loved one. Hopefully, by identifying these people and helping them to avoid the onset of PGD (perhaps by providing psychotherapy soon after a death) and/or providing better treatment for PGD, it should now be possible to reduce the considerable personal and societal costs associated with prolonged grief.

          Additional Information

          Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000121.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: not found
          • Article: not found

          Progress in development of the index of ADL.

            • Record: found
            • Abstract: not found
            • Article: not found

            SYMPTOMATOLOGY AND MANAGEMENT OF ACUTE GRIEF

              • Record: found
              • Abstract: found
              • Article: not found

              Treatment of complicated grief: a randomized controlled trial.

              Complicated grief is a debilitating disorder associated with important negative health consequences, but the results of existing treatments for it have been disappointing. To compare the efficacy of a novel approach, complicated grief treatment, with a standard psychotherapy (interpersonal psychotherapy). Two-cell, prospective, randomized controlled clinical trial, stratified by manner of death of loved one and treatment site. A university-based psychiatric research clinic as well as a satellite clinic in a low-income African American community between April 2001 and April 2004. A total of 83 women and 12 men aged 18 to 85 years recruited through professional referral, self-referral, and media announcements who met criteria for complicated grief. Participants were randomly assigned to receive interpersonal psychotherapy (n = 46) or complicated grief treatment (n = 49); both were administered in 16 sessions during an average interval of 19 weeks per participant. Treatment response, defined either as independent evaluator-rated Clinical Global Improvement score of 1 or 2 or as time to a 20-point or better improvement in the self-reported Inventory of Complicated Grief. Both treatments produced improvement in complicated grief symptoms. The response rate was greater for complicated grief treatment (51%) than for interpersonal psychotherapy (28%; P = .02) and time to response was faster for complicated grief treatment (P = .02). The number needed to treat was 4.3. Complicated grief treatment is an improved treatment over interpersonal psychotherapy, showing higher response rates and faster time to response.

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                August 2009
                August 2009
                4 August 2009
                : 6
                : 8
                : e1000121
                Affiliations
                [1 ]Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
                [2 ]Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America
                [3 ]Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America
                [4 ]Department of Psychiatry, University of California School of Medicine, San Francisco, California, United States of America
                [5 ]Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America
                [6 ]St. Christopher's Hospice, Sydenham, and St. Joseph's Hospice, Hackney, England
                [7 ]Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
                [8 ]Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
                [9 ]Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America
                [10 ]Department of Population Mental Health and Disasters, University of Western Sydney Medical School, New South Wales, Australia
                [11 ]Department of Psychology, University of Missouri, St. Louis, Missouri, United States of America
                [12 ]Department of Psychology, State University of New York at Stony Brook, New York, United States of America
                [13 ]Department of Psychology, The University of Memphis, Memphis, Tennessee, United States of America
                [14 ]Department of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, New York, United States of America
                [15 ]Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
                [16 ]Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands
                [17 ]Department of Clinical Psychology, University of Zürich, Zürich, Switzerland
                [18 ]Veterans Affairs Boston Healthcare System, Boston, Massachusetts, United States of America
                [19 ]National Center for PTSD, Boston, Massachusetts, United States of America
                [20 ]Boston University School of Medicine, Boston, Massachusetts, United States of America
                [21 ]Department of Psychiatry, Columbia University, New York, New York, United States of America
                University of Cambridge, United Kingdom
                Author notes

                ICMJE criteria for authorship read and met: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Agree with the manuscript's results and conclusions: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Designed the experiments/the study: HGP MJH PKM. Analyzed the data: PKM HGP MA. Collected data/did experiments for the study: HGP PKM. Enrolled patients: HGP. Wrote the first draft of the paper: HGP PKM. Contributed to the writing of the paper: HGP MJH SCJ CMP BR SJM CW RAN GB SDB DK PB AM JGJ MF PKM. Contributed to the conceptualisation: BR. Contributed items to the scale to assess PGD: CW. Assisted with interpretation of the results and contributed to the writing of the final manuscript, and reviewed and approved the contributions of others: RAN.

                Article
                08-PLME-RA-0640R2
                10.1371/journal.pmed.1000121
                2711304
                19652695
                96f4658d-ac89-4a0f-8e84-e69cfcf233e1
                Prigerson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 10 March 2008
                : 25 June 2009
                Page count
                Pages: 12
                Categories
                Research Article
                Mental Health/Anxiety Disorders
                Mental Health/Mood Disorders

                Medicine
                Medicine

                Comments

                Comment on this article

                Related Documents Log